DalsnaFinance › IPOs › TScan Therapeutics › IPO
TScan Therapeutics, Inc. completed its initial public offering on NASDAQ on July 16, 2021, pricing at $15.00 a share.
| Ticker | TCRX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 16, 2021 |
| Offering price | $15.00 |
| Shares offered | 6,666,667 |
| Total raised | $100M |
TScan Therapeutics, Inc. sold 6,666,667 shares at $15.00 each on NASDAQ. Multiplied out, that is $100 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $100 million total recorded for the deal.
TScan Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for TScan Therapeutics, Inc.. This page is general information, not investment advice.